GlassScriptPhysician profile
Brian M Rubenstein
NPI 1336315878
$1,851.72
in general payments reported to CMS, 2019-2025
10 companies · $276 in 2025
The $276 reported for 2025 was more than what 81% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $552 · 2020: $653 · 2021: $179 · 2022: $13.30 · 2023: $45.44 · 2024: $133 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445 · Gift: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.16 |
| Gift | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dmg America LLC | $639.95 | 2020 | |
| Straumann USA LLC | $498.48 | 2019-2021 | |
| Patterson Companies, INC. | $204.62 | 2024-2025 | |
| A-Dec, INC. | $190.00 | 2019 | |
| Kulzer, LLC | $134.09 | 2019-2025 | |
| Orapharma, A Division of Bausch Health US, LLC | $74.23 | 2023-2025 | Ossix Plus, Arestin |
| Dentsply Sirona INC | $71.52 | 2020-2025 | Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive, Cavitron |
| Align Technology, INC. | $15.11 | 2019 | |
| Envista Holdings Corporation | $14.72 | 2024 | Optibond Xtr |
| Meisinger USA, LLC | $9.00 | 2023 | Hm31r-010-Fg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Rubenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.